BERLIN: More encouraging results have emerged from the coronavirus vaccine developed by two major pharmaceutical companies.
German biotech firm BioNTech and US pharmaceutical company Pfizer reported on Monday, citing more important data regarding their experimental COVID-19 vaccine, that the vaccine is safe and is causing immune reactions in patients. Is.
The companies also said that according to the data, the vaccine also produced a high level of T cell response in patients against the new corona virus.
The results were revealed during a vaccine trial in Germany, where the vaccine was tested on 60 healthy volunteers. Earlier, data from a trial in the United States were released earlier this month.
Two vaccines for the corona virus have been awarded by the US Agency for International Development
A trial in Germany, similar to the one in the United States, found that two doses of the vaccine produced antibodies that neutralized the virus.
This data has been put on an online server before it is published, where it will be carefully reviewed by other experts to see if it can be published.
It is worth noting that 150 possible vaccines are currently being developed around the world to prevent the global outbreak of the corona virus, 23 of which have already entered the testing phase in humans.
However, experts say it will still take 12 to 18 months for a safe and effective vaccine to arrive.
